Canadian Journal of Ophthalmology10.1016/j.jcjo.2021.06.0152021Impact of patient face mask use on endophthalmitis after intravitreal anti–VEGF injectionsMélanie Hébert, Eunice You, Karim Hammamji, Serge Bourgault, Mathieu Caissie, Éric Tourville, Ali Dirani,
Graefe's Archive for Clinical and Experimental Ophthalmology10.1007/s00417-009-1171-x20092482295-296Fever after intravitreal anti-VEGF injectionsIoannis D. Ladas, Athanasios I. Kotsolis,,
Clinical Ophthalmology10.2147/opth.s100082010703Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degenerationTimothy G. Timothy Murray
Case Reports in Ophthalmology10.1159/0005203562022131134-140Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case SeriesCharbel Wahab, Jad Ayash, Kevin Sayegh, Fady Sammouh, Elias L. Warrak,
The Open Ophthalmology Journal10.2174/1874364101408010101201481101-104Incidence of Retinal Pigment Epithelial Tears and Associated Risk Factors After Treatment of Age-Related Macular Degeneration with Intravitreal Anti-VEGF Injections§Theodoros Empeslidis, Athanasios Vardarinos, Vasileios Konidaris, Soon Wai Ch'ng, Bharat Kapoor, James Deane, Konstantinos T Tsaousis,,
International Ophthalmology10.1007/s10792-022-02383-62022Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world settingJan Niklas Lüke, Hamdi Alquoqa, Ahmad Alsamman, Bayan Aljabary, F. Schaub, L. M. Heindl,,
Ophthalmology Retina10.1016/j.oret.2018.04.025201827643-644Real-World Papers, Prophylaxis for Intravitreal Injections, Fluorescein Angiography and Neovascular Age-Related Macular Degeneration, and Anti–Vascular Endothelial Growth Factor SafetyAndrew P. Schachat,
Clinical Ophthalmology10.2147/opth.s770672015773Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysisShlomit Schaal, Douglas Sigford, Shivani Reddy, Christine Mollineaux
American Journal of Ophthalmology10.1016/j.ajo.2015.07.00120151604842-843Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual OutcomeAndrzej Grzybowski,
Ophthalmology10.1016/j.ophtha.2018.02.034201812591386-1392Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF InjectionsAnthony Obeid, Xinxiao Gao, Ferhina S. Ali, Katherine E. Talcott, Christopher M. Aderman, Leslie Hyman, Allen C. Ho, Jason Hsu,